Overview

A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether multiple dose administration is safe and well tolerated in patients with mild to moderate Alzheimer's Disease.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer